$ROL

UBS Adjusts Price Target on Rollins to $43 From $50, Maintains Neutral Rating

UBS cut its price target on Rollins (ROL) to $43 from $50 and kept a Neutral rating, according to the note. The article also cites BNP Paribas raising its target to $44 from $63 with a Neutral rating. Rollins last traded at $39.44, with an average analyst target of $47.94.

Original reporting
Published Jul 24, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ROL
Neutral
medium confidence
Mentioned
$ROL
Relevance
5/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$ROLNeutralLow
01

Why it matters

Lowering the target to $43 from $50 can pressure near-term sentiment, but the maintained Neutral rating implies UBS does not see a major fundamental deterioration in the thesis based on the information provided.

02

Market read

This is a modest, analyst-driven valuation signal for ROL, with limited actionable information beyond the revised target.

03

What to watch

The article also mentions another bank (BNP Paribas) adjusting its target, which could indicate a broader target-trimming cycle; however, the text provides no new company performance data to confirm deterioration.

Relevance 5/10Novelty 4/10Timing: today’s analyst note update (published 2026-07-24)

Background

The piece is a sell-side target change for Rollins, describing its business mix and noting the US is 92.8% of net sales.

Company-level read

Ticker impact

$ROLNeutralMedium confidence
Context

UBS cut Rollins’ price target to $43 from $50 while keeping a Neutral rating, signaling a less favorable valuation outlook.

Expected impact

Near-term bias slightly negative, with limited follow-through unless other firms also cut targets or cite new fundamentals.

Evidence & confidence

The only new, company-specific datapoint in the text is UBS’ revised target ($43) versus prior ($50) and the maintained Neutral stance; no new earnings, guidance, or operational event is provided.

Market effects

Could modestly affect sentiment for business support services/inspection and pest control peers if target cuts cluster, but no peer-specific actions are detailed.

No regional macro or cross-market linkage is provided beyond the US sales mix.

Limited global relevance; this is a single-name sell-side target adjustment.

Counterpoint

A Neutral rating with a lower target may reflect valuation normalization rather than deteriorating fundamentals, so the stock may not re-rate much if the market already priced in weakness.

Key entities

  • Rollins, Inc.

    Inspection and pest control services provider; UBS adjusted its price target to $43 from $50 and kept Neutral.

  • UBS

    Issued the price target cut and maintained Neutral rating for Rollins.

  • BNP Paribas

    Also adjusted Rollins’ price target to $44 from $63 and maintained Neutral (mentioned in the text).

Related articles

$ROLMedAI 8/10

Rollins shares drop 9.3% after Q2 earnings

Rollins, Inc. reported Q2 2026 operating margin of 18.7%, down 110 bps year over year, and operating cash flow of $173 million, down 1.5%. CEO Jerry Gahlhoff said results missed expectations due to a weaker lead environment and fewer customers using digital pest-control searches. Rollins shares fell about 9.27%.

$ROLMed

JPMorgan cuts Rollins to Neutral on demand uncertainty, slashes price target

JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, citing uncertainty from weakening residential demand and a slower margin recovery. It lowered fiscal 2026/2027 revenue growth forecasts to 8.7% and 8.4%, adjusted EBITDA margins to 21.9% and 22.2%, and adjusted EPS to $1.17 and $1.26. The move follows a weaker Q2 with declining lead volumes.

$ROLMedAI 8/10

Rollins Analysts Cut Their Forecasts After Downbeat Q2 Earnings - Rollins (NYSE:ROL)

Rollins Inc (NYSE:ROL) reported Q2 results after the close. Earnings were 32 cents per share versus a 34-cent consensus, and sales were $1.079 billion versus $1.092 billion expected. Shares fell 1.7% to $38.78 premarket. After the report, JP Morgan cut its target to $45 from $70 and downgraded to Neutral, while Wells Fargo cut to $32 from $46 and downgraded to Underweight.

$ROLMed

Wells Fargo says ditch this pest control stock as demand continues to soften

Wells Fargo downgraded Rollins (ROL) to underweight from equal weight and cut its price target to $32 from $46, citing softer residential pest-control demand. The bank cited headwinds including weather, potential impacts from LLMs, more aggressive competition, and more price-sensitive consumers. Rollins reported 5.7% organic growth, missed Q2 estimates, and lowered FY2026 guidance to about 6%.